Core Viewpoint - The company has signed a cooperation agreement to establish an "International Precision Medicine Center for Oncology" with Hainan Boao Super Hospital, which is expected to enhance its business development in the longevity science sector [1] Group 1: Cooperation Agreement Details - The agreement was signed on September 13, 2025, between Zhongli (Hainan) Life Science Technology Co., Ltd. and Hainan Boao Super Hospital [1] - Hainan Boao will provide the center's facilities and services, while Zhongli Hainan will manage operations and provide expert support and specialized equipment [1] Group 2: Market Outlook - The board believes that the longevity science market has significant potential, as affluent clients are increasingly willing to invest in longevity applications to improve their overall health and immune status [1] - The cooperation aligns with the company's strategic development plans in the longevity science sector, laying a solid foundation for future domestic market expansion [1] Group 3: Revenue Growth Potential - The agreement is expected to enhance the company's positioning in the longevity science diagnostics and medical services field, opening new revenue streams [1] - The board anticipates that this initiative will lead to more stable and sustainable revenue growth in the long term [1]

Core Viewpoint - The company has signed a cooperation agreement to establish an "International Precision Medicine Center for Oncology" with Hainan Boao Super Hospital, which is expected to enhance its business development in the longevity science sector [1] Group 1: Partnership Details - The indirect non-wholly owned subsidiary of the company, Zhongli (Hainan) Life Science Technology Co., Ltd., will collaborate with Hainan Boao Super Hospital to jointly operate the medical center [1] - Hainan Boao will provide the facility and services for outpatient, inpatient, examination, treatment, and surgery, while Zhongli Hainan will manage operations and provide expert support and specialized equipment [1] Group 2: Market Outlook - The board believes that the longevity science market has significant potential, as affluent clients are increasingly willing to invest in longevity science applications to enhance their overall health and immune status [1] - The cooperation agreement aligns with the company's development strategy in longevity science and is expected to solidify its foundation for expanding into the domestic market [1] Group 3: Future Growth Potential - The agreement is anticipated to improve the company's positioning in the longevity science diagnostic and medical service sectors, opening new revenue streams [1] - The board expects this initiative to contribute to more stable and sustainable revenue growth in the long term [1]

Group 1 - The company, Zhongji Changshou Science (00767.HK), has signed a cooperation agreement with Hainan Boao Super Hospital to establish an "International Precision Medicine Center for Oncology" [1] - Hainan Boao will provide the center's facilities and services, while Zhongji Changshou will manage operations and provide expert support and specialized equipment [1] - The Boao Super Hospital is recognized as a pioneer in China's medical field, leveraging special policies to utilize advanced foreign medical technologies and services [1] Group 2 - The board believes that the market for longevity science is promising, as affluent clients are increasingly willing to invest in longevity applications to enhance their health and vitality [2] - The cooperation agreement aligns with the company's strategy for developing longevity science, laying a solid foundation for future business expansion in the domestic market [2] - The agreement is expected to enhance the company's positioning in the longevity science diagnostic and medical service sectors, creating new revenue streams for stable and sustainable growth [2]